SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/130044"
 

Search: onr:"swepub:oai:gup.ub.gu.se/130044" > Extracapsular tumor...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.

Gruber, G (author)
Cole, B F (author)
Castiglione-Gertsch, M (author)
show more...
Holmberg, Stig B, 1946 (author)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences
Lindtner, J (author)
Golouh, R (author)
Collins, J (author)
Crivellari, D (author)
Thürlimann, B (author)
Simoncini, E (author)
Fey, M F (author)
Gelber, R D (author)
Coates, A S (author)
Price, K N (author)
Goldhirsch, A (author)
Viale, G (author)
Gusterson, B A (author)
Hultborn, Ragnar, 1946 (author)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences
show less...
 (creator_code:org_t)
Elsevier BV, 2008
2008
English.
In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. - : Elsevier BV. - 1569-8041. ; 19:8, s. 1393-401
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND: Extracapsular tumor spread (ECS) has been identified as a possible risk factor for breast cancer recurrence, but controversy exists regarding its role in decision making for regional radiotherapy. This study evaluates ECS as a predictor of local, axillary, and supraclavicular recurrence. PATIENTS AND METHODS: International Breast Cancer Study Group Trial VI accrued 1475 eligible pre- and perimenopausal women with node-positive breast cancer who were randomly assigned to receive three to nine courses of classical combination chemotherapy with cyclophosphamide, methotrexate, and fluorouracil. ECS status was determined retrospectively in 933 patients based on review of pathology reports. Cumulative incidence and hazard ratios (HRs) were estimated using methods for competing risks analysis. Adjustment factors included treatment group and baseline patient and tumor characteristics. The median follow-up was 14 years. RESULTS: In univariable analysis, ECS was significantly associated with supraclavicular recurrence (HR = 1.96; 95% confidence interval 1.23-3.13; P = 0.005). HRs for local and axillary recurrence were 1.38 (P = 0.06) and 1.81 (P = 0.11), respectively. Following adjustment for number of lymph node metastases and other baseline prognostic factors, ECS was not significantly associated with any of the three recurrence types studied. CONCLUSIONS: Our results indicate that the decision for additional regional radiotherapy should not be based solely on the presence of ECS.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kirurgi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Surgery (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Adult
Antineoplastic Combined Chemotherapy Protocols
administration & dosage
therapeutic use
Breast Neoplasms
drug therapy
pathology
radiotherapy
Combined Modality Therapy
Cyclophosphamide
administration & dosage
Female
Fluorouracil
administration & dosage
Follow-Up Studies
Humans
Lymphatic Metastasis
Methotrexate
administration & dosage
Neoplasm Recurrence
Local
pathology
Neoplasm Staging
Premenopause
Retrospective Studies
Treatment Outcome

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view